Position in AUTL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,568,146
+$22,501 QoQ
Shares Held
1,605,092
-13.0% QoQ
Ownership
0.603%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 84 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. AUTL ranks #175 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in AUTL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,568,146 | 1,605,092 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,545,645 | 1,844,671 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $3,901,923 | 1,960,766 | Shares | Defined | 2026-02-17 | |
| 2025-06-30 | $2,223,307 | 975,135 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $50,522 | 32,595 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $109,504 | 46,598 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $969,354 | 267,040 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $882,154 | 253,493 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,668,534 | 261,526 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $265,913 | 41,291 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,449 | 622 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $11,507 | 4,835 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,201 | 653 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $982 | 517 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,105 | 517 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,770 | 626 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $11,274 | 2,704 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $91,842 | 17,696 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $92,951 | 14,191 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,407 | 212 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $152,400 | 26,597 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $5,042 | 564 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $336,838 | 28,938 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $881 | 55 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,815 | 470 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||